Mark Howard Snyder - 16 Feb 2023 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, GENERAL COUNSEL
Signature
/s/ James R. Oehler, Attorney-in-Fact
Issuer symbol
HALO
Transactions as of
16 Feb 2023
Net transactions value
$0
Form type
4
Filing time
21 Feb 2023, 18:02:39 UTC
Previous filing
04 Jan 2023
Next filing
05 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Option to Purchase Common Stock Award $0 +54,955 $0.000000 54,955 16 Feb 2023 Common Stock 54,955 $49.26 Direct F1
transaction HALO Restricted Stock Units Award $0 +19,184 $0.000000 19,184 16 Feb 2023 Common Stock 19,184 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests one-fourth on such date and then 1/48th monthly thereafter.
F2 This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.